Gan & Lee Pharmaceuticals
http://www.ganlee.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Gan & Lee Pharmaceuticals
China Rings In New Year With Major Deals, Record IPOs And Trends To Watch
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.
Chi-Med's Surufatinib, Generic Ibrance Among Latest China Approvals
China's innovative drug makers step into the spotlight by grabbing green lights for cancer drugs in the country's latest batch of product approvals.
Journey East: How Chinese Returnees Build Global-Bound Biopharmas
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
Journey East: How Chinese Returnees Build Global-Bound Biopharmas
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Gan & Lee Pharmaceuticals Shandong Co., Ltd
- Gangan Medical Technology Jiangsu Co., Ltd.